

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.37515159 |
| 2 | reverse cholesterol transport (GO:0043691) | 6.16435069 |
| 3 | high-density lipoprotein particle remodeling (GO:0034375) | 5.86405983 |
| 4 | low-density lipoprotein particle remodeling (GO:0034374) | 5.84302123 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.41191188 |
| 6 | plasma lipoprotein particle remodeling (GO:0034369) | 5.37547403 |
| 7 | protein-lipid complex remodeling (GO:0034368) | 5.37547403 |
| 8 | macromolecular complex remodeling (GO:0034367) | 5.37547403 |
| 9 | regulation of cholesterol esterification (GO:0010872) | 5.37361029 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 5.27456513 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.27456513 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.09606954 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 5.09606954 |
| 14 | cellular modified amino acid catabolic process (GO:0042219) | 4.78928749 |
| 15 | negative regulation of sterol transport (GO:0032372) | 4.64555138 |
| 16 | negative regulation of cholesterol transport (GO:0032375) | 4.64555138 |
| 17 | L-serine metabolic process (GO:0006563) | 4.55551485 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 4.53354613 |
| 19 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.52193726 |
| 20 | fucose catabolic process (GO:0019317) | 4.49937316 |
| 21 | L-fucose metabolic process (GO:0042354) | 4.49937316 |
| 22 | L-fucose catabolic process (GO:0042355) | 4.49937316 |
| 23 | phospholipid efflux (GO:0033700) | 4.47435428 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 4.42680835 |
| 25 | alanine transport (GO:0032328) | 4.42510510 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.39344660 |
| 27 | plasma lipoprotein particle organization (GO:0071827) | 4.36744522 |
| 28 | cellular response to cholesterol (GO:0071397) | 4.32379731 |
| 29 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.30955715 |
| 30 | plasma lipoprotein particle assembly (GO:0034377) | 4.30875508 |
| 31 | negative regulation of astrocyte differentiation (GO:0048712) | 4.30698983 |
| 32 | cysteine metabolic process (GO:0006534) | 4.29586497 |
| 33 | behavioral response to nicotine (GO:0035095) | 4.28758114 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.13653407 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.12612525 |
| 36 | glutamate metabolic process (GO:0006536) | 4.09287929 |
| 37 | glyoxylate metabolic process (GO:0046487) | 4.07560929 |
| 38 | protein-lipid complex subunit organization (GO:0071825) | 4.04287100 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 3.98523858 |
| 40 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93870701 |
| 41 | carnitine metabolic process (GO:0009437) | 3.92660684 |
| 42 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.92422564 |
| 43 | cholesterol catabolic process (GO:0006707) | 3.90936779 |
| 44 | sterol catabolic process (GO:0016127) | 3.90936779 |
| 45 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.84622763 |
| 46 | ethanol oxidation (GO:0006069) | 3.82146728 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 3.80163720 |
| 48 | serine family amino acid biosynthetic process (GO:0009070) | 3.79644137 |
| 49 | cellular response to sterol (GO:0036315) | 3.78896746 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 3.77510856 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 3.77510856 |
| 52 | tryptophan catabolic process (GO:0006569) | 3.77510856 |
| 53 | linoleic acid metabolic process (GO:0043651) | 3.75730199 |
| 54 | protein-lipid complex assembly (GO:0065005) | 3.75628726 |
| 55 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75434161 |
| 56 | bile acid biosynthetic process (GO:0006699) | 3.75039210 |
| 57 | dicarboxylic acid catabolic process (GO:0043649) | 3.73317551 |
| 58 | urea cycle (GO:0000050) | 3.73048587 |
| 59 | urea metabolic process (GO:0019627) | 3.73048587 |
| 60 | cholesterol efflux (GO:0033344) | 3.73029461 |
| 61 | purine nucleotide transport (GO:0015865) | 3.72566106 |
| 62 | short-chain fatty acid metabolic process (GO:0046459) | 3.67868429 |
| 63 | regulation of cholesterol metabolic process (GO:0090181) | 3.66916982 |
| 64 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.64958606 |
| 65 | kynurenine metabolic process (GO:0070189) | 3.63303463 |
| 66 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.62221743 |
| 67 | cellular amino acid catabolic process (GO:0009063) | 3.61240688 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 3.59743967 |
| 69 | adenine nucleotide transport (GO:0051503) | 3.57886097 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 3.57395168 |
| 71 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.56096415 |
| 72 | response to pheromone (GO:0019236) | 3.54013172 |
| 73 | platelet dense granule organization (GO:0060155) | 3.53069006 |
| 74 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.52205976 |
| 75 | very long-chain fatty acid metabolic process (GO:0000038) | 3.48983349 |
| 76 | coenzyme catabolic process (GO:0009109) | 3.48576786 |
| 77 | negative regulation of fibrinolysis (GO:0051918) | 3.48171375 |
| 78 | tryptophan metabolic process (GO:0006568) | 3.44041659 |
| 79 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.40758953 |
| 80 | positive regulation of action potential (GO:0045760) | 3.38159251 |
| 81 | regulation of fibrinolysis (GO:0051917) | 3.37045540 |
| 82 | nitrogen cycle metabolic process (GO:0071941) | 3.36925009 |
| 83 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.35722743 |
| 84 | nephron epithelium morphogenesis (GO:0072088) | 3.35030656 |
| 85 | nephron tubule morphogenesis (GO:0072078) | 3.35030656 |
| 86 | serine family amino acid metabolic process (GO:0009069) | 3.31239836 |
| 87 | lipoprotein metabolic process (GO:0042157) | 3.31015490 |
| 88 | negative regulation of telomere maintenance (GO:0032205) | 3.30793241 |
| 89 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.30323642 |
| 90 | purine ribonucleotide transport (GO:0015868) | 3.30305303 |
| 91 | fatty acid homeostasis (GO:0055089) | 3.26913253 |
| 92 | glutamine family amino acid catabolic process (GO:0009065) | 3.26227210 |
| 93 | fructose metabolic process (GO:0006000) | 3.24421476 |
| 94 | arginine metabolic process (GO:0006525) | 3.24141094 |
| 95 | dopamine transport (GO:0015872) | 3.20619359 |
| 96 | aspartate family amino acid catabolic process (GO:0009068) | 3.19474178 |
| 97 | bile acid metabolic process (GO:0008206) | 3.19399789 |
| 98 | regulation of triglyceride metabolic process (GO:0090207) | 3.18197273 |
| 99 | regulation of beta-amyloid formation (GO:1902003) | 3.17603531 |
| 100 | tyrosine metabolic process (GO:0006570) | 3.17423548 |
| 101 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.17063715 |
| 102 | cornea development in camera-type eye (GO:0061303) | 3.16726585 |
| 103 | basic amino acid transport (GO:0015802) | 3.15338215 |
| 104 | indolalkylamine metabolic process (GO:0006586) | 3.15116874 |
| 105 | respiratory chain complex IV assembly (GO:0008535) | 3.13536068 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.12019003 |
| 107 | positive regulation of steroid metabolic process (GO:0045940) | 3.11229459 |
| 108 | lysine metabolic process (GO:0006553) | 3.10835821 |
| 109 | lysine catabolic process (GO:0006554) | 3.10835821 |
| 110 | positive regulation of fatty acid transport (GO:2000193) | 3.10259575 |
| 111 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.09902302 |
| 112 | aromatic amino acid family metabolic process (GO:0009072) | 3.09834474 |
| 113 | 2-oxoglutarate metabolic process (GO:0006103) | 3.08789032 |
| 114 | flavonoid metabolic process (GO:0009812) | 3.06507267 |
| 115 | positive regulation of fatty acid oxidation (GO:0046321) | 3.05164702 |
| 116 | cellular ketone body metabolic process (GO:0046950) | 3.05113280 |
| 117 | gap junction assembly (GO:0016264) | 3.04828718 |
| 118 | kidney morphogenesis (GO:0060993) | 3.02252364 |
| 119 | regulation of action potential (GO:0098900) | 2.96577286 |
| 120 | S-adenosylmethionine metabolic process (GO:0046500) | 2.96538117 |
| 121 | piRNA metabolic process (GO:0034587) | 2.96042424 |
| 122 | C4-dicarboxylate transport (GO:0015740) | 2.95184235 |
| 123 | DNA deamination (GO:0045006) | 2.94940368 |
| 124 | ketone body metabolic process (GO:1902224) | 2.94922221 |
| 125 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.93503991 |
| 126 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.93318028 |
| 127 | exogenous drug catabolic process (GO:0042738) | 2.89842583 |
| 128 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.87331797 |
| 129 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.85873951 |
| 130 | NADH dehydrogenase complex assembly (GO:0010257) | 2.85873951 |
| 131 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.85873951 |
| 132 | renal tubule morphogenesis (GO:0061333) | 2.84078567 |
| 133 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.83745398 |
| 134 | positive regulation of icosanoid secretion (GO:0032305) | 2.82703338 |
| 135 | regulation of hexokinase activity (GO:1903299) | 2.79602603 |
| 136 | regulation of glucokinase activity (GO:0033131) | 2.79602603 |
| 137 | positive regulation of defense response to virus by host (GO:0002230) | 2.78245632 |
| 138 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.77044476 |
| 139 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.74209021 |
| 140 | primary amino compound metabolic process (GO:1901160) | 2.72317872 |
| 141 | protein complex biogenesis (GO:0070271) | 2.72194295 |
| 142 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.71884107 |
| 143 | detection of light stimulus involved in visual perception (GO:0050908) | 2.71299582 |
| 144 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.71299582 |
| 145 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.67742053 |
| 146 | drug catabolic process (GO:0042737) | 2.67468928 |
| 147 | protein polyglutamylation (GO:0018095) | 2.67136669 |
| 148 | L-methionine salvage (GO:0071267) | 2.65116606 |
| 149 | L-methionine biosynthetic process (GO:0071265) | 2.65116606 |
| 150 | amino acid salvage (GO:0043102) | 2.65116606 |
| 151 | auditory receptor cell stereocilium organization (GO:0060088) | 2.64209063 |
| 152 | positive regulation of prostaglandin secretion (GO:0032308) | 2.60811239 |
| 153 | positive regulation of mitochondrial fission (GO:0090141) | 2.60737625 |
| 154 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.60622776 |
| 155 | cellular response to ATP (GO:0071318) | 2.60067533 |
| 156 | cytochrome complex assembly (GO:0017004) | 2.58830979 |
| 157 | cell proliferation in forebrain (GO:0021846) | 2.58339657 |
| 158 | negative regulation of mast cell activation (GO:0033004) | 2.58030338 |
| 159 | mannosylation (GO:0097502) | 2.57366650 |
| 160 | organic cation transport (GO:0015695) | 2.54940074 |
| 161 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.53731276 |
| 162 | behavioral response to ethanol (GO:0048149) | 2.53600508 |
| 163 | indole-containing compound metabolic process (GO:0042430) | 2.53505774 |
| 164 | cilium morphogenesis (GO:0060271) | 2.53388662 |
| 165 | positive regulation of organic acid transport (GO:0032892) | 2.51984954 |
| 166 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.51528641 |
| 167 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.51528641 |
| 168 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.51496508 |
| 169 | aldehyde catabolic process (GO:0046185) | 2.47903812 |
| 170 | nucleobase catabolic process (GO:0046113) | 2.47521032 |
| 171 | positive regulation of gastrulation (GO:2000543) | 2.47379776 |
| 172 | neurotransmitter metabolic process (GO:0042133) | 2.46969066 |
| 173 | fucosylation (GO:0036065) | 2.46911140 |
| 174 | retinal cone cell development (GO:0046549) | 2.46697101 |
| 175 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.45735609 |
| 176 | amine catabolic process (GO:0009310) | 2.44649141 |
| 177 | cellular biogenic amine catabolic process (GO:0042402) | 2.44649141 |
| 178 | neuronal action potential (GO:0019228) | 2.39856231 |
| 179 | protein-cofactor linkage (GO:0018065) | 2.38688799 |
| 180 | epithelial cilium movement (GO:0003351) | 2.38313263 |
| 181 | somite development (GO:0061053) | 2.38005944 |
| 182 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.36256444 |
| 183 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.36256444 |
| 184 | inner ear receptor stereocilium organization (GO:0060122) | 2.35649249 |
| 185 | endoderm formation (GO:0001706) | 2.35034682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.61444790 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.59435923 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.60493421 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.38337118 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.35406301 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.91784862 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.61714294 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60720076 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.97885250 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.65190719 |
| 11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.64989509 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.62050149 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.57184716 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.55319760 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.29146122 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29136077 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.10408910 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.10122262 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86728328 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83218593 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82807878 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74948062 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.72085428 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68708860 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68648843 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.64556767 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.62282118 |
| 28 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.62107979 |
| 29 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.61795264 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.61371692 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61057756 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58077774 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.56230723 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.54414201 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.53135799 |
| 36 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.51796935 |
| 37 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.49444239 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.49374319 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45814606 |
| 40 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.45554299 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45254554 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.42913832 |
| 43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.42813306 |
| 44 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.40887893 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40007976 |
| 46 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39896476 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38417651 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38187918 |
| 49 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38187918 |
| 50 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38124505 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37445602 |
| 52 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.37335703 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33838317 |
| 54 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.33365715 |
| 55 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.31017781 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30593897 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29755261 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29447402 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28935523 |
| 60 | EWS_26573619_Chip-Seq_HEK293_Human | 1.28464928 |
| 61 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.28007243 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27276110 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27276110 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26855490 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26548318 |
| 66 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.26215441 |
| 67 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.26152500 |
| 68 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.25215518 |
| 69 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.25215518 |
| 70 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24109338 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23131025 |
| 72 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.22756731 |
| 73 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21489046 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20687656 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20560517 |
| 76 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20520329 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20373197 |
| 78 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.20158405 |
| 79 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.19999303 |
| 80 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18799356 |
| 81 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18487730 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18149732 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17741456 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17518177 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16767726 |
| 86 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16597284 |
| 87 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16447668 |
| 88 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.15993119 |
| 89 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.14526595 |
| 90 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14493620 |
| 91 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14493620 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14404285 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14245485 |
| 94 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11366360 |
| 95 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.10860427 |
| 96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10622334 |
| 97 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09555710 |
| 98 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.09173804 |
| 99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07900421 |
| 100 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05750337 |
| 101 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03656527 |
| 102 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03298224 |
| 103 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.03121289 |
| 104 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03059371 |
| 105 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.01882424 |
| 106 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01745967 |
| 107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.00602984 |
| 108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00250628 |
| 109 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97071995 |
| 110 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96989527 |
| 111 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96585493 |
| 112 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.96517506 |
| 113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.96040145 |
| 114 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95561001 |
| 115 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.95165265 |
| 116 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.95161970 |
| 117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94973352 |
| 118 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93798486 |
| 119 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93763252 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93544606 |
| 121 | ERA_21632823_ChIP-Seq_H3396_Human | 0.93003972 |
| 122 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.91074289 |
| 123 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90577380 |
| 124 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88670110 |
| 125 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87786350 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86348909 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84486043 |
| 128 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84467126 |
| 129 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.84106111 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83851100 |
| 131 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.83202691 |
| 132 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.82587663 |
| 133 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81922213 |
| 134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81396378 |
| 135 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81301334 |
| 136 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81010684 |
| 137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77978788 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77978788 |
| 139 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.77653614 |
| 140 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75790501 |
| 141 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75585804 |
| 142 | P300_19829295_ChIP-Seq_ESCs_Human | 0.74676430 |
| 143 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73611813 |
| 144 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73365470 |
| 145 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.73206353 |
| 146 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.73013905 |
| 147 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.71788566 |
| 148 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.71135198 |
| 149 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70211129 |
| 150 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.69631364 |
| 151 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.69613532 |
| 152 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69052416 |
| 153 | AR_25329375_ChIP-Seq_VCAP_Human | 0.68762498 |
| 154 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.68280677 |
| 155 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.67600353 |
| 156 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.67173137 |
| 157 | AR_19668381_ChIP-Seq_PC3_Human | 0.66370338 |
| 158 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.65196916 |
| 159 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.64622534 |
| 160 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.64126816 |
| 161 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.63929176 |
| 162 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.62977108 |
| 163 | TP53_16413492_ChIP-PET_HCT116_Human | 0.62031192 |
| 164 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.61841928 |
| 165 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.61650188 |
| 166 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.61615561 |
| 167 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.61615561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.97347291 |
| 2 | MP0005360_urolithiasis | 4.83278066 |
| 3 | MP0009840_abnormal_foam_cell | 4.75668111 |
| 4 | MP0005365_abnormal_bile_salt | 4.24886434 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.11199151 |
| 6 | MP0002254_reproductive_system_inflammat | 3.90573208 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.33098329 |
| 8 | MP0003011_delayed_dark_adaptation | 3.23196065 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.19310472 |
| 10 | MP0005332_abnormal_amino_acid | 3.05726127 |
| 11 | MP0003329_amyloid_beta_deposits | 2.98759465 |
| 12 | MP0003690_abnormal_glial_cell | 2.81700586 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.73043173 |
| 14 | MP0003283_abnormal_digestive_organ | 2.60807784 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.60250339 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.58591782 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 2.58347173 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.57739489 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.25335509 |
| 20 | MP0000604_amyloidosis | 2.20729852 |
| 21 | MP0004147_increased_porphyrin_level | 2.19946105 |
| 22 | MP0003252_abnormal_bile_duct | 2.18533405 |
| 23 | MP0000566_synostosis | 2.16171510 |
| 24 | MP0002736_abnormal_nociception_after | 2.13237768 |
| 25 | MP0009384_cardiac_valve_regurgitation | 2.06958606 |
| 26 | MP0004858_abnormal_nervous_system | 2.06030481 |
| 27 | MP0001986_abnormal_taste_sensitivity | 1.96412706 |
| 28 | MP0002234_abnormal_pharynx_morphology | 1.88649349 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.86573153 |
| 30 | MP0002638_abnormal_pupillary_reflex | 1.86524222 |
| 31 | MP0002938_white_spotting | 1.83166959 |
| 32 | MP0002102_abnormal_ear_morphology | 1.80353647 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.76196421 |
| 34 | MP0001853_heart_inflammation | 1.74408488 |
| 35 | MP0005083_abnormal_biliary_tract | 1.73003118 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.71593751 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.67004035 |
| 38 | MP0003279_aneurysm | 1.66660461 |
| 39 | MP0004019_abnormal_vitamin_homeostasis | 1.66056853 |
| 40 | MP0004859_abnormal_synaptic_plasticity | 1.59837742 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.51036509 |
| 42 | MP0003195_calcinosis | 1.50382445 |
| 43 | MP0003075_altered_response_to | 1.46823795 |
| 44 | MP0002272_abnormal_nervous_system | 1.46758500 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.46645203 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.45511644 |
| 47 | MP0004885_abnormal_endolymph | 1.45441789 |
| 48 | MP0008775_abnormal_heart_ventricle | 1.45416539 |
| 49 | MP0001486_abnormal_startle_reflex | 1.44721876 |
| 50 | MP0002933_joint_inflammation | 1.40759840 |
| 51 | MP0000609_abnormal_liver_physiology | 1.39597858 |
| 52 | MP0003787_abnormal_imprinting | 1.35340712 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.34261060 |
| 54 | MP0004130_abnormal_muscle_cell | 1.34051901 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 1.29898504 |
| 56 | MP0003878_abnormal_ear_physiology | 1.29898504 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29456566 |
| 58 | MP0005647_abnormal_sex_gland | 1.27823035 |
| 59 | MP0003186_abnormal_redox_activity | 1.27548438 |
| 60 | MP0004133_heterotaxia | 1.23572119 |
| 61 | MP0003868_abnormal_feces_composition | 1.21152336 |
| 62 | MP0005671_abnormal_response_to | 1.17737581 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 1.17698873 |
| 64 | MP0003122_maternal_imprinting | 1.16486076 |
| 65 | MP0001440_abnormal_grooming_behavior | 1.16410089 |
| 66 | MP0005670_abnormal_white_adipose | 1.16205826 |
| 67 | MP0002090_abnormal_vision | 1.15780094 |
| 68 | MP0002909_abnormal_adrenal_gland | 1.14104605 |
| 69 | MP0009764_decreased_sensitivity_to | 1.12517738 |
| 70 | MP0001984_abnormal_olfaction | 1.12185516 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.11106693 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 1.10488348 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.10286899 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 1.09243849 |
| 75 | MP0000427_abnormal_hair_cycle | 1.09211673 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.06409687 |
| 77 | MP0005195_abnormal_posterior_eye | 1.05573351 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 1.05103794 |
| 79 | MP0005174_abnormal_tail_pigmentation | 1.02982670 |
| 80 | MP0001661_extended_life_span | 1.02124319 |
| 81 | MP0001764_abnormal_homeostasis | 1.01225735 |
| 82 | MP0000049_abnormal_middle_ear | 1.01157366 |
| 83 | MP0003880_abnormal_central_pattern | 1.00976590 |
| 84 | MP0001970_abnormal_pain_threshold | 1.00812901 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.99013639 |
| 86 | MP0000778_abnormal_nervous_system | 0.97772374 |
| 87 | MP0002067_abnormal_sensory_capabilities | 0.97650325 |
| 88 | MP0005503_abnormal_tendon_morphology | 0.95687012 |
| 89 | MP0002572_abnormal_emotion/affect_behav | 0.94994980 |
| 90 | MP0000372_irregular_coat_pigmentation | 0.94719873 |
| 91 | MP0003635_abnormal_synaptic_transmissio | 0.94316824 |
| 92 | MP0008789_abnormal_olfactory_epithelium | 0.94295170 |
| 93 | MP0000026_abnormal_inner_ear | 0.94100614 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.93079081 |
| 95 | MP0003119_abnormal_digestive_system | 0.92452879 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.91658648 |
| 97 | MP0004043_abnormal_pH_regulation | 0.91389896 |
| 98 | MP0002735_abnormal_chemical_nociception | 0.90848730 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.90320344 |
| 100 | MP0002064_seizures | 0.90299313 |
| 101 | MP0002127_abnormal_cardiovascular_syste | 0.89136095 |
| 102 | MP0002063_abnormal_learning/memory/cond | 0.88073962 |
| 103 | MP0003136_yellow_coat_color | 0.87989129 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.87868737 |
| 105 | MP0003633_abnormal_nervous_system | 0.87386469 |
| 106 | MP0001324_abnormal_eye_pigmentation | 0.86916287 |
| 107 | MP0000639_abnormal_adrenal_gland | 0.84906376 |
| 108 | MP0000631_abnormal_neuroendocrine_gland | 0.83178854 |
| 109 | MP0003718_maternal_effect | 0.82853717 |
| 110 | MP0009745_abnormal_behavioral_response | 0.82762560 |
| 111 | MP0009697_abnormal_copulation | 0.81661026 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.80128154 |
| 113 | MP0004883_abnormal_blood_vessel | 0.79556093 |
| 114 | MP0003634_abnormal_glial_cell | 0.79521730 |
| 115 | MP0004084_abnormal_cardiac_muscle | 0.79477168 |
| 116 | MP0003632_abnormal_nervous_system | 0.78552886 |
| 117 | MP0010030_abnormal_orbit_morphology | 0.77743978 |
| 118 | MP0002282_abnormal_trachea_morphology | 0.77095435 |
| 119 | MP0003121_genomic_imprinting | 0.76989226 |
| 120 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76962565 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.75933638 |
| 122 | MP0000613_abnormal_salivary_gland | 0.75564090 |
| 123 | MP0005451_abnormal_body_composition | 0.75496418 |
| 124 | MP0004742_abnormal_vestibular_system | 0.75204451 |
| 125 | MP0003631_nervous_system_phenotype | 0.74699672 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.74215366 |
| 127 | MP0005535_abnormal_body_temperature | 0.73884070 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.73406927 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.72461805 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.71855733 |
| 131 | MP0002876_abnormal_thyroid_physiology | 0.71120491 |
| 132 | MP0005166_decreased_susceptibility_to | 0.70545210 |
| 133 | MP0002971_abnormal_brown_adipose | 0.69467714 |
| 134 | MP0002557_abnormal_social/conspecific_i | 0.68091496 |
| 135 | MP0001501_abnormal_sleep_pattern | 0.67229638 |
| 136 | MP0005165_increased_susceptibility_to | 0.65703125 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.65307531 |
| 138 | MP0005376_homeostasis/metabolism_phenot | 0.63675903 |
| 139 | MP0008874_decreased_physiological_sensi | 0.63584635 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.62030170 |
| 141 | MP0002733_abnormal_thermal_nociception | 0.61456024 |
| 142 | MP0006292_abnormal_olfactory_placode | 0.61385101 |
| 143 | MP0000647_abnormal_sebaceous_gland | 0.60402638 |
| 144 | MP0009046_muscle_twitch | 0.60275553 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.59462747 |
| 146 | MP0004142_abnormal_muscle_tone | 0.58557873 |
| 147 | MP0003646_muscle_fatigue | 0.56475227 |
| 148 | MP0002822_catalepsy | 0.55353961 |
| 149 | MP0001529_abnormal_vocalization | 0.54371229 |
| 150 | MP0009642_abnormal_blood_homeostasis | 0.53020009 |
| 151 | MP0001881_abnormal_mammary_gland | 0.50741685 |
| 152 | MP0002078_abnormal_glucose_homeostasis | 0.50437621 |
| 153 | MP0005386_behavior/neurological_phenoty | 0.50170110 |
| 154 | MP0004924_abnormal_behavior | 0.50170110 |
| 155 | MP0005164_abnormal_response_to | 0.48732859 |
| 156 | MP0005253_abnormal_eye_physiology | 0.48537649 |
| 157 | MP0001905_abnormal_dopamine_level | 0.47645537 |
| 158 | MP0008872_abnormal_physiological_respon | 0.47563817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 6.34990434 |
| 2 | Hyperlipoproteinemia (HP:0010980) | 6.06500718 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.37920916 |
| 4 | Hypoalphalipoproteinemia (HP:0003233) | 5.21869429 |
| 5 | Hyperglycinuria (HP:0003108) | 4.67371419 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.66330660 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.66298200 |
| 8 | Megalencephaly (HP:0001355) | 4.53257355 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 4.52090641 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.52090641 |
| 11 | Aplasia of the phalanges of the hand (HP:0009802) | 4.43255249 |
| 12 | Aplasia involving bones of the extremities (HP:0009825) | 4.43255249 |
| 13 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.43255249 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.34643818 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.33976640 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 4.30706613 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 4.23507803 |
| 18 | Pancreatic cysts (HP:0001737) | 4.20682758 |
| 19 | Congenital stationary night blindness (HP:0007642) | 4.07759523 |
| 20 | Hyperglycinemia (HP:0002154) | 4.05516911 |
| 21 | Hyperammonemia (HP:0001987) | 4.03124464 |
| 22 | Abnormality of the axillary hair (HP:0100134) | 3.94365185 |
| 23 | Abnormality of secondary sexual hair (HP:0009888) | 3.94365185 |
| 24 | Nephronophthisis (HP:0000090) | 3.90090710 |
| 25 | Ketosis (HP:0001946) | 3.87931747 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 3.84768431 |
| 27 | Type II lissencephaly (HP:0007260) | 3.81728037 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 3.78442580 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 3.78442580 |
| 30 | Pancreatic fibrosis (HP:0100732) | 3.72527538 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.67611905 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.65248042 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 3.60224244 |
| 34 | True hermaphroditism (HP:0010459) | 3.59710391 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.57870785 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.53368519 |
| 37 | Epidermoid cyst (HP:0200040) | 3.48597980 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.47291643 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.22592376 |
| 40 | Back pain (HP:0003418) | 3.22383161 |
| 41 | Ketoacidosis (HP:0001993) | 3.13315481 |
| 42 | Late onset (HP:0003584) | 3.06969302 |
| 43 | Abnormality of the renal medulla (HP:0100957) | 3.05859017 |
| 44 | Joint hemorrhage (HP:0005261) | 3.05631518 |
| 45 | Increased corneal curvature (HP:0100692) | 3.01770103 |
| 46 | Keratoconus (HP:0000563) | 3.01770103 |
| 47 | Dry hair (HP:0011359) | 2.97249572 |
| 48 | Hypoplastic left heart (HP:0004383) | 2.96185164 |
| 49 | Tetraparesis (HP:0002273) | 2.94510080 |
| 50 | Abnormality of the renal cortex (HP:0011035) | 2.90548262 |
| 51 | Tubular atrophy (HP:0000092) | 2.83916940 |
| 52 | Abnormal drinking behavior (HP:0030082) | 2.74345538 |
| 53 | Polydipsia (HP:0001959) | 2.74345538 |
| 54 | Pseudobulbar signs (HP:0002200) | 2.73661856 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.73277630 |
| 56 | Chronic hepatic failure (HP:0100626) | 2.68367947 |
| 57 | Status epilepticus (HP:0002133) | 2.66845207 |
| 58 | Abnormality of proline metabolism (HP:0010907) | 2.64709787 |
| 59 | Hydroxyprolinuria (HP:0003080) | 2.64709787 |
| 60 | Cystic liver disease (HP:0006706) | 2.60809735 |
| 61 | Large for gestational age (HP:0001520) | 2.60532970 |
| 62 | Confusion (HP:0001289) | 2.59416098 |
| 63 | Broad alveolar ridges (HP:0000187) | 2.58311374 |
| 64 | Complement deficiency (HP:0004431) | 2.55990591 |
| 65 | Clumsiness (HP:0002312) | 2.50838430 |
| 66 | Delayed CNS myelination (HP:0002188) | 2.48865717 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 2.48765590 |
| 68 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.46825556 |
| 69 | Mitochondrial inheritance (HP:0001427) | 2.44099299 |
| 70 | Inability to walk (HP:0002540) | 2.43962263 |
| 71 | Medial flaring of the eyebrow (HP:0010747) | 2.43946122 |
| 72 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.43096569 |
| 73 | Enlarged kidneys (HP:0000105) | 2.42822159 |
| 74 | Atrioventricular block (HP:0001678) | 2.42498120 |
| 75 | Sensorimotor neuropathy (HP:0007141) | 2.42240265 |
| 76 | Amyloidosis (HP:0011034) | 2.42001276 |
| 77 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.40954123 |
| 78 | Pendular nystagmus (HP:0012043) | 2.39405593 |
| 79 | Lissencephaly (HP:0001339) | 2.38646846 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.37700461 |
| 81 | Synostosis involving the elbow (HP:0003938) | 2.37173744 |
| 82 | Humeroradial synostosis (HP:0003041) | 2.37173744 |
| 83 | Increased CSF lactate (HP:0002490) | 2.37039169 |
| 84 | Congenital, generalized hypertrichosis (HP:0004540) | 2.36822617 |
| 85 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.36815563 |
| 86 | Absent/shortened dynein arms (HP:0200106) | 2.36815563 |
| 87 | Attenuation of retinal blood vessels (HP:0007843) | 2.36784124 |
| 88 | Acute necrotizing encephalopathy (HP:0006965) | 2.36319463 |
| 89 | Abnormality of alanine metabolism (HP:0010916) | 2.35191887 |
| 90 | Hyperalaninemia (HP:0003348) | 2.35191887 |
| 91 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.35191887 |
| 92 | Congenital hepatic fibrosis (HP:0002612) | 2.32234934 |
| 93 | Cerebellar dysplasia (HP:0007033) | 2.31863944 |
| 94 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.31102594 |
| 95 | Arthropathy (HP:0003040) | 2.30698397 |
| 96 | Neonatal hypoglycemia (HP:0001998) | 2.28902122 |
| 97 | Renal cortical cysts (HP:0000803) | 2.28111316 |
| 98 | Abolished electroretinogram (ERG) (HP:0000550) | 2.27402025 |
| 99 | Gout (HP:0001997) | 2.27264604 |
| 100 | Absent hair (HP:0002298) | 2.27031366 |
| 101 | Acute encephalopathy (HP:0006846) | 2.24926367 |
| 102 | Hypoplastic heart (HP:0001961) | 2.17143928 |
| 103 | Metabolic acidosis (HP:0001942) | 2.16774075 |
| 104 | Paraparesis (HP:0002385) | 2.15774041 |
| 105 | Short middle phalanx of the 5th finger (HP:0004220) | 2.14802877 |
| 106 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.14351305 |
| 107 | Abnormality of the common coagulation pathway (HP:0010990) | 2.12463742 |
| 108 | Severe muscular hypotonia (HP:0006829) | 2.09815248 |
| 109 | Progressive inability to walk (HP:0002505) | 2.09441628 |
| 110 | Abnormality of binocular vision (HP:0011514) | 2.08720652 |
| 111 | Diplopia (HP:0000651) | 2.08720652 |
| 112 | Hypothermia (HP:0002045) | 2.08610432 |
| 113 | Hypoglycemic seizures (HP:0002173) | 2.08111852 |
| 114 | Adactyly (HP:0009776) | 2.08029793 |
| 115 | Progressive macrocephaly (HP:0004481) | 2.07060179 |
| 116 | Lethargy (HP:0001254) | 2.05315370 |
| 117 | Mixed hearing impairment (HP:0000410) | 2.04235038 |
| 118 | Onycholysis (HP:0001806) | 2.04059490 |
| 119 | Myocardial infarction (HP:0001658) | 2.03954543 |
| 120 | Concave nail (HP:0001598) | 2.03510703 |
| 121 | Skin nodule (HP:0200036) | 2.01786087 |
| 122 | Mesangial abnormality (HP:0001966) | 2.01595510 |
| 123 | Hyperventilation (HP:0002883) | 2.00950078 |
| 124 | Hypertriglyceridemia (HP:0002155) | 2.00701101 |
| 125 | Duplicated collecting system (HP:0000081) | 2.00131160 |
| 126 | Polyuria (HP:0000103) | 2.00099856 |
| 127 | Methylmalonic acidemia (HP:0002912) | 1.99824217 |
| 128 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.98512675 |
| 129 | Irritability (HP:0000737) | 1.98211662 |
| 130 | Hyperbilirubinemia (HP:0002904) | 1.97506417 |
| 131 | Esophageal varix (HP:0002040) | 1.97296847 |
| 132 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.97129595 |
| 133 | Pachygyria (HP:0001302) | 1.97063541 |
| 134 | Hepatocellular necrosis (HP:0001404) | 1.95632836 |
| 135 | Thyroid-stimulating hormone excess (HP:0002925) | 1.95245138 |
| 136 | Abnormality of the renal collecting system (HP:0004742) | 1.94702151 |
| 137 | Bronchomalacia (HP:0002780) | 1.94674509 |
| 138 | Optic disc pallor (HP:0000543) | 1.94429468 |
| 139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94143053 |
| 140 | Fat malabsorption (HP:0002630) | 1.93786329 |
| 141 | Asplenia (HP:0001746) | 1.93512536 |
| 142 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.93116207 |
| 143 | Dicarboxylic aciduria (HP:0003215) | 1.93116207 |
| 144 | Split foot (HP:0001839) | 1.92348271 |
| 145 | Turricephaly (HP:0000262) | 1.91603298 |
| 146 | Hepatic necrosis (HP:0002605) | 1.90524936 |
| 147 | Decreased central vision (HP:0007663) | 1.90371096 |
| 148 | Abnormality of nail color (HP:0100643) | 1.90071483 |
| 149 | Prenatal maternal abnormality (HP:0002686) | 1.89905125 |
| 150 | Lipid accumulation in hepatocytes (HP:0006561) | 1.89481774 |
| 151 | Cholecystitis (HP:0001082) | 1.88969857 |
| 152 | Abnormal gallbladder physiology (HP:0012438) | 1.88969857 |
| 153 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87755855 |
| 154 | Furrowed tongue (HP:0000221) | 1.87578659 |
| 155 | Hypoplasia of the fovea (HP:0007750) | 1.87488738 |
| 156 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.87488738 |
| 157 | Retinal dysplasia (HP:0007973) | 1.87326079 |
| 158 | Short hallux (HP:0010109) | 1.87128979 |
| 159 | Bifid scrotum (HP:0000048) | 1.86630666 |
| 160 | Postaxial foot polydactyly (HP:0001830) | 1.83329386 |
| 161 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.83225993 |
| 162 | Stage 5 chronic kidney disease (HP:0003774) | 1.82506956 |
| 163 | Narrow forehead (HP:0000341) | 1.82397147 |
| 164 | Mitral stenosis (HP:0001718) | 1.82330700 |
| 165 | Disproportionate short-trunk short stature (HP:0003521) | 1.81443540 |
| 166 | Sclerocornea (HP:0000647) | 1.81255176 |
| 167 | Abnormality of the pons (HP:0007361) | 1.80870715 |
| 168 | Male pseudohermaphroditism (HP:0000037) | 1.79736890 |
| 169 | Optic nerve hypoplasia (HP:0000609) | 1.78058412 |
| 170 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77983078 |
| 171 | Gait imbalance (HP:0002141) | 1.77645100 |
| 172 | Hemiparesis (HP:0001269) | 1.77573518 |
| 173 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77456503 |
| 174 | Patellar aplasia (HP:0006443) | 1.76495200 |
| 175 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.76434589 |
| 176 | Anterior segment dysgenesis (HP:0007700) | 1.74884023 |
| 177 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.72905485 |
| 178 | Global brain atrophy (HP:0002283) | 1.72470306 |
| 179 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.72435153 |
| 180 | Thyroiditis (HP:0100646) | 1.72171471 |
| 181 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.71928753 |
| 182 | Heart block (HP:0012722) | 1.71927759 |
| 183 | Gaze-evoked nystagmus (HP:0000640) | 1.71862266 |
| 184 | Abnormal biliary tract physiology (HP:0012439) | 1.71552691 |
| 185 | Bile duct proliferation (HP:0001408) | 1.71552691 |
| 186 | Increased hepatocellular lipid droplets (HP:0006565) | 1.71024592 |
| 187 | Abnormal urine output (HP:0012590) | 1.70750148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.82318305 |
| 2 | LMTK2 | 4.98938675 |
| 3 | FRK | 4.67310385 |
| 4 | TRIB3 | 4.28713564 |
| 5 | SIK1 | 3.79134358 |
| 6 | ADRBK2 | 3.71128834 |
| 7 | PHKG1 | 3.70996912 |
| 8 | PHKG2 | 3.70996912 |
| 9 | MAP4K2 | 3.54253315 |
| 10 | BCKDK | 3.26550305 |
| 11 | NTRK2 | 3.13334721 |
| 12 | GRK1 | 3.07460746 |
| 13 | WNK4 | 2.81662382 |
| 14 | WNK3 | 2.52376372 |
| 15 | BMPR1B | 2.28854574 |
| 16 | TLK1 | 2.24230673 |
| 17 | TXK | 2.23272821 |
| 18 | MUSK | 2.22899512 |
| 19 | TAOK3 | 2.06059818 |
| 20 | TNIK | 1.99213725 |
| 21 | MAPK12 | 1.91748346 |
| 22 | PINK1 | 1.91542882 |
| 23 | DAPK2 | 1.78831513 |
| 24 | IRAK3 | 1.70576897 |
| 25 | TESK2 | 1.69859549 |
| 26 | NTRK3 | 1.66032522 |
| 27 | NUAK1 | 1.58299116 |
| 28 | ACVR1B | 1.51219980 |
| 29 | ERN1 | 1.46782674 |
| 30 | GRK6 | 1.43682256 |
| 31 | MAP2K4 | 1.43309048 |
| 32 | FGFR2 | 1.42361534 |
| 33 | NTRK1 | 1.42211790 |
| 34 | MAPK7 | 1.37743374 |
| 35 | PRKCG | 1.33832834 |
| 36 | ZAK | 1.29108355 |
| 37 | SGK2 | 1.23259863 |
| 38 | MKNK2 | 1.13349873 |
| 39 | FGR | 1.12544680 |
| 40 | KSR2 | 1.10526245 |
| 41 | SGK494 | 1.08063345 |
| 42 | SGK223 | 1.08063345 |
| 43 | DYRK1A | 1.08058870 |
| 44 | MINK1 | 1.07629977 |
| 45 | CSNK1G2 | 1.06907979 |
| 46 | INSRR | 1.05881123 |
| 47 | SGK3 | 1.02224101 |
| 48 | ERBB4 | 1.01674592 |
| 49 | CSNK1G3 | 1.01354068 |
| 50 | ERBB3 | 1.00814789 |
| 51 | DYRK2 | 0.98431119 |
| 52 | FGFR1 | 0.96848395 |
| 53 | STK39 | 0.96023967 |
| 54 | PRKD3 | 0.93345264 |
| 55 | MKNK1 | 0.90713937 |
| 56 | PKN2 | 0.89530553 |
| 57 | CSNK1G1 | 0.89518913 |
| 58 | AKT3 | 0.85545971 |
| 59 | KIT | 0.84983528 |
| 60 | MAP3K4 | 0.84763291 |
| 61 | FGFR4 | 0.84013228 |
| 62 | MAP2K7 | 0.82444714 |
| 63 | MAPKAPK3 | 0.81995200 |
| 64 | KSR1 | 0.81980785 |
| 65 | TRIM28 | 0.81744472 |
| 66 | TGFBR1 | 0.79157930 |
| 67 | CDK5 | 0.79108696 |
| 68 | PLK2 | 0.77605032 |
| 69 | STK38L | 0.75980889 |
| 70 | CAMKK2 | 0.75655814 |
| 71 | CAMK2G | 0.74679748 |
| 72 | TIE1 | 0.72763262 |
| 73 | PRKAA2 | 0.72727336 |
| 74 | CSNK1A1L | 0.71017795 |
| 75 | BMX | 0.70653985 |
| 76 | SIK2 | 0.70648621 |
| 77 | PRKCE | 0.69601716 |
| 78 | PDPK1 | 0.69454633 |
| 79 | SRPK1 | 0.68392005 |
| 80 | BCR | 0.68207008 |
| 81 | MAPKAPK5 | 0.67809831 |
| 82 | GRK5 | 0.67741116 |
| 83 | PAK3 | 0.67722095 |
| 84 | PIK3CA | 0.67398924 |
| 85 | MAP2K6 | 0.67153812 |
| 86 | CASK | 0.66907787 |
| 87 | PRKCH | 0.66195734 |
| 88 | SIK3 | 0.65473844 |
| 89 | MAPK4 | 0.65016570 |
| 90 | CAMK2A | 0.64666142 |
| 91 | PAK6 | 0.64467761 |
| 92 | PRKD2 | 0.63918416 |
| 93 | PDK2 | 0.62760526 |
| 94 | VRK2 | 0.62288948 |
| 95 | PRKACG | 0.61633292 |
| 96 | PRKCI | 0.60991297 |
| 97 | MAPK11 | 0.60316078 |
| 98 | VRK1 | 0.57941886 |
| 99 | AKT2 | 0.57878722 |
| 100 | PRKCQ | 0.56534630 |
| 101 | PTK2B | 0.55717851 |
| 102 | PDK1 | 0.55545469 |
| 103 | IGF1R | 0.55489988 |
| 104 | MAP2K1 | 0.55069813 |
| 105 | MYLK | 0.52387142 |
| 106 | ADRBK1 | 0.50850226 |
| 107 | CAMKK1 | 0.50734237 |
| 108 | PRKCA | 0.50353385 |
| 109 | MAP3K7 | 0.49493026 |
| 110 | ERBB2 | 0.48343443 |
| 111 | TAOK2 | 0.47670678 |
| 112 | OXSR1 | 0.47266036 |
| 113 | STK38 | 0.46912889 |
| 114 | PTK6 | 0.46332775 |
| 115 | PRKCZ | 0.46163325 |
| 116 | IKBKB | 0.45753306 |
| 117 | NEK6 | 0.44486018 |
| 118 | CAMK1 | 0.44226715 |
| 119 | JAK3 | 0.43170031 |
| 120 | MAP3K13 | 0.42880381 |
| 121 | RPS6KA3 | 0.41362143 |
| 122 | MAP3K9 | 0.41204885 |
| 123 | ABL2 | 0.40862783 |
| 124 | SGK1 | 0.40270604 |
| 125 | MAP3K2 | 0.38879517 |
| 126 | FLT3 | 0.38519705 |
| 127 | PRKACA | 0.38155659 |
| 128 | MARK3 | 0.37998701 |
| 129 | TGFBR2 | 0.37189939 |
| 130 | MET | 0.37044736 |
| 131 | JAK2 | 0.36038057 |
| 132 | PKN1 | 0.35551500 |
| 133 | GRK7 | 0.33692310 |
| 134 | LRRK2 | 0.31600888 |
| 135 | TYRO3 | 0.31391846 |
| 136 | SRC | 0.31282713 |
| 137 | MAPK13 | 0.30024638 |
| 138 | STK3 | 0.29647542 |
| 139 | ABL1 | 0.29171188 |
| 140 | RET | 0.27737661 |
| 141 | PRKACB | 0.27652410 |
| 142 | CAMK2B | 0.27601481 |
| 143 | PRKCB | 0.27221828 |
| 144 | ROCK1 | 0.27071728 |
| 145 | PRKAA1 | 0.26842131 |
| 146 | EPHB2 | 0.25326343 |
| 147 | PDGFRA | 0.24326911 |
| 148 | PIK3CG | 0.23372842 |
| 149 | ICK | 0.21854835 |
| 150 | MARK1 | 0.21099326 |
| 151 | EGFR | 0.20698395 |
| 152 | CSNK1A1 | 0.19326136 |
| 153 | PRKG1 | 0.19070178 |
| 154 | CDK15 | 0.17142028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.54935927 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.44124361 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.17754135 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.08557979 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97722271 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92821223 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.74512543 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.73012296 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45886214 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.41043298 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34382368 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.32269682 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23024086 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.19614084 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19402303 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09019826 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.03458933 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.01721883 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.96214870 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.92359771 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92054919 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.91107474 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.89845602 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80177479 |
| 25 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.76343248 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.73767541 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.72500959 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.54875967 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54097177 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.48949483 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47992486 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.46299588 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.42105665 |
| 34 | Protein export_Homo sapiens_hsa03060 | 1.40942379 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33163680 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32561520 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31174596 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30665717 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30029611 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28840519 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28440978 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26437534 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21088924 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20321287 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19634430 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13329394 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12272581 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08360761 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06445492 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03342281 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03288079 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03023306 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02808485 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.02221303 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 1.00267756 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 0.99171496 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97799083 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96110387 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95138809 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94805864 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93388778 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92912312 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92046151 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90704701 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85554048 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85132146 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83816175 |
| 68 | Proteasome_Homo sapiens_hsa03050 | 0.82704102 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82555324 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80982832 |
| 71 | RNA polymerase_Homo sapiens_hsa03020 | 0.80888566 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79570763 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.78714465 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.77216036 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76572821 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72147397 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71596000 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70032321 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68683668 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68046018 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64909358 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64338035 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62485210 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62319186 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.61781223 |
| 86 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60827516 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59116483 |
| 88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58821360 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57726141 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.55503674 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55113782 |
| 92 | RNA degradation_Homo sapiens_hsa03018 | 0.51795083 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49845457 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45750222 |
| 95 | Nicotine addiction_Homo sapiens_hsa05033 | 0.45088094 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43853308 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42994850 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42155845 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41850720 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41429468 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41002365 |
| 102 | Asthma_Homo sapiens_hsa05310 | 0.40243648 |
| 103 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.37978667 |
| 104 | GABAergic synapse_Homo sapiens_hsa04727 | 0.37486892 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.35231098 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33452188 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32887899 |
| 108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31642130 |
| 109 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31204678 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30327539 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.26910863 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.18734391 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.17208941 |
| 114 | Insulin secretion_Homo sapiens_hsa04911 | 0.17056717 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.16421960 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14904892 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12350459 |
| 118 | Salivary secretion_Homo sapiens_hsa04970 | 0.10977004 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.09420902 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.08197903 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.06519897 |
| 122 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.05390727 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.04536065 |
| 124 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.03921383 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03365872 |
| 126 | Morphine addiction_Homo sapiens_hsa05032 | 0.02914103 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.02826611 |
| 128 | Malaria_Homo sapiens_hsa05144 | 0.02434237 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.00089399 |
| 130 | Gastric acid secretion_Homo sapiens_hsa04971 | -0.0024593 |
| 131 | Circadian entrainment_Homo sapiens_hsa04713 | -0.0024076 |

